Therapeutic trials in general practice, an unmet need

Area of Science:

• General Practice
• Clinical Pharmacology
• Health Services Research

Background:

• Most drugs are prescribed in general practice, yet clinical drug trials are infrequently conducted within this setting.
• Low participation rates among general practitioners (GPs) in drug trials are likely due to insufficient motivation and training.
• Specific therapeutic areas are more amenable to general practice research than others, with challenges including time, funding, and complex study designs.

Purpose of the Study:

• To explore the reasons for the underrepresentation of general practice in clinical drug trials.
• To define the roles of GPs in drug trials (data collector and project leader).
• To provide guidance for GPs considering involvement in sponsored research.

Main Methods:

• Qualitative analysis of barriers and facilitators for GP participation in clinical drug trials.
• Definition of GP roles within trial structures.
• Development of a checklist for GPs evaluating research proposals from sponsors.

Main Results:

• Identified lack of motivation and training as primary barriers for GP involvement.
• Outlined distinct roles for GPs as data collectors or project leaders.
• Presented a framework for GPs to assess the feasibility and suitability of drug trial participation.

Conclusions:

• Improving GP engagement in clinical drug trials is essential for advancing primary healthcare pharmacotherapy.
• Addressing training and motivational deficits is key to increasing GP participation.
• GPs and the broader medical community share responsibility for facilitating research that leads to better patient care.